Research Paper Volume 12, Issue 19 pp 19546—19562

Comparison of exosomes derived from induced pluripotent stem cells and mesenchymal stem cells as therapeutic nanoparticles for treatment of corneal epithelial defects

class="figure-viewer-img"

Effect of iPSCs/MSCs-Exos on corneal epithelial defect healing in vivo. (A) Schematic diagram of the experimental procedure. After corneal epithelial defect and treated with iPSCs/MSCs-Exos every 6 h, different procedures were performed at relative time point. (B) The corneal epithelial defect area was monitored every 6 hours with fluorescein staining and slit lamp. (C) The corneal epithelial defect healing rates are shown in line graphs. The cornea healing area in iPSCs-Exos group increased obviously compared with that in the vehicle group and was statistically significant at 12, 30, 36, 42, and 48 h compared with control group. (D) Central corneal thickness was measured by AS-OCT at both 24 and 48 h. (E) Central corneal thickness is shown by bar graph. Central corneal thickness in the iPSCs-Exos group was statistically different from that of the control. (F) A 3D-pattern was generated by AS-OCT for rat corneas at 36 h, enabling a more stereoscopic view of the corneal epithelial defects. (G) Rat eyeballs were harvested 48 h after corneal defect and were stained with hematoxylin and eosin. Data are representative of one of three independent experiments performed. Each experiment consisted of 4 animals/group. The values are shown as the mean ± SEM. * P<0.05, ** P<0.01.